Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

GeneMedicine expands collaboration with Merck for GeneSwitch technology

Nov. 25, 1998

AVI BioPharma presents advantages of CytoPorter drug delivery engine

Nov. 25, 1998

Supratek, RPR Gencell work together to improve delivery of cardiovascular gene therapy

Nov. 23, 1998

Myriad Genetics and Monsanto collaborate on drug target discovery

Nov. 18, 1998

Medarex and Novartis licensing agreement for HuMAb-Mouse technology

Nov. 16, 1998

Novalon signs research agreement with Millennium

Nov. 16, 1998

S-18127 characterized as a selective, structurally novel 5-HT1B/1D receptor antagonist

Nov. 12, 1998

Sangamo enters agreement with Zeneca for identification of novel gene targets

Nov. 10, 1998

MitoKor and Pfizer to collaborate on mitochondrial targets for neurodegenerative diseases

Nov. 10, 1998

Corixa invests in, works with ImmGenics to develop high-potency monoclonal antibodies

Nov. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...